Replies to post #19902 on Mymetics Corp (MYMX)

[bow-tie]

Antiviral properties of two trimeric recombinant gp41 proteins.
Rgp41A and Rgp41B were patented by Mymetics Corporation (ref PCT/IB2004/002433). Production of HIV-1 pseudotyped and laboratory-adapted strains Stocks of pseudotyped viruses were generated by co-transfecting HEK293 cells with the proviral plasmid pNL4.3-?env-Luc and one of the env encoding plasmids.
http://europepmc.org/article/PMC/1435769#figures-and-tables

Sars Cov-2 Recombinant Protein Antigens
HEK293
https://abclonal.com/recombinant-protein-antigen/?msclkid=116156ef70fb1b17ae2109ab7863ff6d

Baylor College Of Medicine HEK293
https://pubmed.ncbi.nlm.nih.gov/23166581/